Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
IndustryARC
www.industryarc.com/
Venkat Reddy
venkat@industryarc.com
(+1) 970-236-3677

Bookmark and Share
Therapeutic Drug Monitoring Market - Forecast(2022 - 2027)
The growing global geriatric population is driving the growth of the market during the forecast period.

BriefingWire.com, 3/03/2022 - The [FURL=https://www.industryarc.com/Report/16821/therapeutic-drug-monitoring-market.html?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]Therapeutic Drug Monitoring Market[/FURL] size is estimated to reach $2.1 billion by 2026, growing at a CAGR of 6.8% during the forecast period 2021-2026. Therapeutic drug monitoring is a test that involves the measurement of various drugs in the bloodstream. It helps to ensure the administered quantity of medicine is enough to be effective and does not cause any major side effects or reactions. Even though most drugs can be taken without the need for therapeutic drug monitoring, some types of anti-epileptics, anti-arrhythmics, immunosuppressants, antibiotics, and psychoactive drugs require monitoring to ensure safety and effectiveness. The key technologies used for therapeutic drug monitoring include immunoassays, chromatography, proteomics, and spectrophotometry.

Key Takeaways

Geographically, the North American Therapeutic Drug Monitoring market accounted for the largest share in 2020 owing to the presence of well-developed healthcare infrastructure and the presence of key industry leaders in the region.

An increase in the cases of cardiovascular disorders and strokes is driving the demand for Therapeutic Drug Monitoring. However, the high cost of the devices is predicted to hamper growth opportunities, especially in developing regions.

Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Therapeutic Drug Monitoring Market Report.

Download Sample Report @ [FURL]www.industryarc.com/pdfdownload.php?id=16821[/FURL]

Therapeutic Drug Monitoring Market Segment Analysis-By Geography

The Therapeutic Drug Monitoring Market based on Geography can be segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. The North American segment is projected to dominate the Therapeutic Drug Monitoring market during the forecast period 2021-2026 with a market share of 32% owing to the presence of highly developed healthcare infrastructure, high per-capita healthcare expenditure, rising cases of lifestyle disorders, and growing geriatric population.

Therapeutic Drug Monitoring Market Drivers

Increase in Geriatric Population is Projected to Drive Market Growth

The rise in Lifestyle disorders is Anticipated to Boost Product Demand

Therapeutic Drug Monitoring Market Industry Outlook:

The top 10 companies of the industry include Abbott Laboratories Inc, Hoffmann-La Roche Ltd, Siemens Healthineers Inc, Thermo Fisher Scientific Inc, Sekisui Medical Co, Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc, bioMérieux, Randox Laboratories Limited

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2026 Proserve Technology, Inc.